BioElectronics from USA,  the makers of ActiPatch has taken proven medical technologies and made them available to more people in new convenient, cost-effective, anti-inflammatory patches. By applying advanced microelectronic technology, BioElectronics has dramatically reduced the size and the cost of some well-established medical treatments.

We, at Astonix Life Science are the distributor for ActiPatch which deliver pulsed electromagnetic frequency (PEMF) therapies to accelerate healing of soft tissue injuries. A reduction of pain and swelling allows patients to return to normal activities much sooner. This patented technology is based on clinically proven, widely accepted PEMF therapy.

ActiPatch is a drug-free, painless, pulsed energy patch. The ActiPatch has FDA clearance for the treatment of edema following blepharoplasty.

We deliver a solution that: . Is drug-free . Reduces swelling and inflammation . Lasts up to 30 days, depending on model . Is comfortable . Provides continuous treatment . Is easy to use . Is safe . Is affordable . Provides localized, non-systemic treatment . Is lightweight

ActiPatch is not:
. Not A Magnet - ActiPatch delivers a pulsed electromagnetic field.
. Not Heat Therapy - ActiPatch is heat free, not a diathermy unit.
. Not A TENS Unit - Unlike TENS, PEMF does not deliver an electrical current through the body to block pain.
. Not A Pharmaceutical - ActiPatch in not ingested or injected and is not systemic.
. Not An Office Based Therapy - ActiPatch can be worn in the comfort of the patient's home.
. Not A Bone Growth Stimulator - ActiPatch is delivers a low power pulse and is not designed to heal hard tissue

ActiPatch accomplishments:
. FDA market clearance for the treatment of edema
. International Standards Organization (ISO) and CE (Conformité Européenne, French for European conformity) Cert.
. Health Canada Market clearance for the relief of musculoskeletal pain

The clinical effectiveness of the product has been well established. Testing performed at the Bioelectromagnetics Research Laboratory at the State University of New York has shown that ActiPatch Therapy provides an adequate dosage of electromagnetic energy for the treatment of soft tissue, and that its power at the skin level is equivalent to that of traditional high-power devices. The power level is six to nine orders of magnitude higher than that which is required to show a biological effect. It also demonstrated that the cumulative effect of continuous delivery provides greater therapeutic benefit than sporadic treatments.

Clinical Trials In 2006, Bioelectronics and the Lahey Clinic jointly announced a three-year program to study the effects of ActiPatch Therapy on a variety of soft tissue injuries and related medical conditions. The internationally renowned Lahey Clinic of Boston, whose faculty is affiliated with the Medical Schools of Harvard and Tufts, has committed to initiating a number of double-blind clinical studies on ActiPatch Therapy in the areas of plastic surgery, orthopedics and chronic wound care. Results from these clinical trials will be submitted to the United States Food and Drug Administration (the FDA) for expanded indications for the use of ActiPatch Therapy.

ActiPatch is also available in small crescent and other presentations notably, the Eye Recovery Kit, the Breast Recovery Kit, Facial Recovery Kit, Rhinoplasty Kit . These are available through selected Plastic & Orthopaedic Surgeons and Doctors, Podiatrists, Physiotherapists and Hospitals.